Guided Therapeutics (GTHP) Net Margin Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -314.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 123.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -296.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1,132.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 656.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -430.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Guided Therapeutics - - 458,000.00 6.98 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 6.98 Mn
Dec 31, 2024 -6.85 Mn
Mar 31, 2024 -294,545.00
Jun 30, 2023 1.65 Mn
Mar 31, 2023 1.67 Mn
Sep 30, 2022 -3.49 Mn
Jun 30, 2022 3.78 Mn
Dec 31, 2021 -932,433.00
Sep 30, 2021 -225,414.00
Dec 31, 2020 170,725.00
Sep 30, 2020 1.46 Mn
Dec 31, 2019 1.33 Mn
Sep 30, 2019 2.53 Mn
Jun 30, 2019 -30.76 Mn
Mar 31, 2019 -2.69 Mn
Dec 31, 2018 19,350.00
Sep 30, 2018 -3.05 Mn
Jun 30, 2018 4.35 Mn
Mar 31, 2018 2.67 Mn
Dec 31, 2017 -717,199.00
Sep 30, 2017 -691,372.00
Dec 31, 2016 2.81 Mn
Sep 30, 2016 3.38 Mn
Dec 31, 2015 -285,983.00
Sep 30, 2015 -2.05 Mn
Jun 30, 2015 -1.01 Mn
Mar 31, 2015 -3,298.00
Dec 31, 2014 -2.36 Mn
Sep 30, 2014 -1.20 Mn
Jun 30, 2014 -1.86 Mn
Mar 31, 2014 -738,686.00
Dec 31, 2013 -110,149.00
Sep 30, 2013 -152,981.00
Jun 30, 2013 -118,822.00
Mar 31, 2013 -122,791.00
Dec 31, 2012 -42,544.00
Sep 30, 2012 -40,291.00
Jun 30, 2012 -7,321.00
Mar 31, 2012 4,643.00
Jun 30, 2011 1,511.00